FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes

Clinical trial NCT00743925 · COMPLETED

Trial details

NCT number: NCT00743925
Sponsor: Anthera Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2008-07-01
Primary completion: 2010-01-01
Enrollment: 625

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.